课题基金 / 基金详情

项目摘要

项目成果

PHILLIP I TARR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: Necrotizing enterocolitis (NEC) is a devastating disorder that affects approximately 10% of premature infants. Its mortality remains high (15-30%), and its cause remains unknown. About 80% of cases occur within 35 days of birth among hospitalized newborns of low birth weight. Probiotics diminish the incidence and severity of NEC, and NEC does not occur antepartum. NEC affects a readily identifiable at-risk group, has a tightly defined interval before its onset, occurs in an organ system that is intimately associated with a microbial population in flux, has a plausible association with the intestinal microbiota, and cohorts at risk have rarely been studied in large numbers, or prospectively. This disorder, therefore, provides a unique opportunity to explore the role of the human enteric microbiome in a devastating disease. Moreover, NEC epidemiology and age-incidence present an ability to enroll and study cohorts that are highly likely to provide valuable pathophysiologic and microbiologic insights. In this project, we will identify and quantify the microbial components of stool and its products before and at the onset of NEC. In doing so, we will test the overarching hypothesis that NEC is a direct or indirect consequence of the enteric biomass, its products, or both. We will use multicenter cohorts of premature infants at high risk of developing NEC, extend our research on this disease currently sponsored by the Washington University Institute of Clinical and Translational Sciences, and continue our longstanding collaborations with the Genome Center at Washington University and the Washington University Digestive Diseases Research Core Center (Informatics Core). The Aims of this proposal are to (1) conduct a case cohort study in which we compare clinical data and biological specimens from cases and well-matched controls; (2) determine if the kind and density of intestinal biomass, its gene content, and transcriptional activity are associated with, and potential determinants of, NEC; and (3) determine if host risk alleles for intestinal inflammation play a role in the development of NEC. These efforts will be accomplished using subjects from three collaborating neonatal intensive care units (NICUs), focusing on the critical, instructive, and understudied pre-NEC stage of illness, and formulating a data repository that will be a resource for investigators worldwide who wish to focus their efforts on NEC, its precipitants, and its prevention and cure. PUBLIC HEALTH RELEVANCE: Necrotizing enterocolitis (NEC) is a devastating complication of prematurity. It occurs suddenly, usually during the first month of life, and we don't know how to prevent it. It is probably more dangerous to premature infants than lung disease today. About one-third of children die and many of the survivors are left with very little intestines. NEC is a disorder that we think might relate to the microbes in the gut. We propose to study this disease intensively, compare cases to controls especially in the days leading up to NEC, and try to determine what differentiates the patients who get this disorder from those who don't. We might then be able to alter these factors, and prevent this abdominal catastrophe from occurring.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pone.0052078
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者: [La Rosa PS, Brooks JP, Deych E, Boone EL, Edwards DJ, Wang Q, Sodergren E, Weinstock G, Shannon WD]
通讯作者: Shannon WD
DOI: 10.1016/j.jpedsurg.2011.03.026
发表时间: 2011-06
期刊: Journal of pediatric surgery
影响因子: 2.4
作者: [Bucher BT, McDuffie LA, Shaikh N, Tarr PI, Warner BB, Hamvas A, White FV, Erwin CR, Warner BW]
通讯作者: Warner BW
DOI: 10.1371/journal.pone.0048996
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者: [La Rosa PS, Shands B, Deych E, Zhou Y, Sodergren E, Weinstock G, Shannon WD]
通讯作者: Shannon WD
The Neonatal Microbiome and Necrotizing Enterocolitis
  • 批准号:
    8134250
  • 项目类别:
  • 资助金额:
    $262.18万
  • 财政年份:
    2009
  • 负责人:
    PHILLIP I TARR
  • 依托单位:
The Neonatal Microbiome and Necrotizing Enterocolitis
  • 批准号:
    8318269
  • 项目类别:
  • 资助金额:
    $248.1万
  • 财政年份:
    2009
  • 负责人:
    PHILLIP I TARR
  • 依托单位:
The Neonatal Microbiome and Necrotizing Enterocolitis
  • 批准号:
    8111454
  • 项目类别:
  • 资助金额:
    $250.0万
  • 财政年份:
    2009
  • 负责人:
    PHILLIP I TARR
  • 依托单位:
STRATEGIC TARGETING OF VIRAL GENOMES IN BILIARY ATRESIA
  • 批准号:
    7599257
  • 项目类别:
  • 资助金额:
    $15.2万
  • 财政年份:
    2008
  • 负责人:
    PHILLIP I TARR
  • 依托单位:
海外基金